OR2AM1P

Across TCGA pan-cancer cohorts, OR2AM1P RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated OR2AM1P data layer.

The strongest signal is observed in cholangiocarcinoma (CHOL), where higher OR2AM1P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR2AM1P expression acts as an unfavorable survival marker.

CHOL, CESC, and PAAD are the cancer types where OR2AM1P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	OS	Tertile	All	0.024	0.728	<.001	108	view →
CESC	DFS	Tertile	All	0.231	0.742	.002	72	view →
PAAD	OS	Tertile	All	0.357	0.618	<.001	51	view →
UCEC	OS	Tertile	All	0.817	0.931	<.001	30	view →
LUAD	DFS	Tertile	All	0.624	0.795	.036	30	view →
SKCM	DFS	Tertile	II,III,IV	0.058	0.708	<.001	27	view →
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	27	view →
ESCA	DFS	Tertile	All	0.153	0.708	.019	18	view →
KIRC	DFS	Tertile	IV	0.217	0.603	.013	18	view →
LUSC	OS	Tertile	II,III,IV	0.161	0.677	.015	18	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →
THCA	DFS	Tertile	All	0.792	0.911	.038	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

OR2AM1P–CHOL (OS)

Open the CHOL breakdown →